The Kentucky Cabinet for Health and Family Services presented information to the legislature’s Interim Joint Committee on Health Services about the impact of the commonwealth’s use of a single PBM since July 1, 2021 and a single Preferred Drug List (PDL) since Jan. 1, 2021. A key finding was how Kentucky would have spent $282.7 million more in its managed Medicaid program if it had not implemented SB 50, the legislation enacting the single PBM and single PDL. Further analysis of SB 50’s impact can be found in the Milliman report. Stay tuned to qAM for more on this story as it develops.
NCPA
